Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.55B |
| 2 |
Comcast
CMCSA
|
+$449M |
| 3 |
SLB Ltd
SLB
|
+$298M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$281M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$229M |
| 2 |
Sempra
SRE
|
+$192M |
| 3 |
Bausch Health
BHC
|
+$183M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$175M |
| 5 |
PepsiCo
PEP
|
+$173M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.58% |
| 2 | Energy | 11.62% |
| 3 | Consumer Discretionary | 8.89% |
| 4 | Financials | 8.63% |
| 5 | Technology | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
AXIS Capital
AXS
$7.25B
| $12.1M | 0.02% |
224,582
+201,558
| +875% | +$11.2M |
|
827
Honda
HMC
$42.3B
| $12.1M | 0.02% |
403,364
+386,876
| +2,346% | +$12.4M |
|
828
Avista
AVA
$3.18B
| $12.1M | 0.02% |
+362,429
| New | +$11.6M |
|
829
ICICI Bank
IBN
$106B
| $12M | 0.02% |
+1,578,887
| New | +$13.5M |
|
830
Invesco QQQ Trust
QQQ
$483B
| $12M | 0.02% |
118,170
+109,435
| +1,253% | +$11.8M |
|
831
CALL
General Motors
GM
$76.3B
| $12M | 0.02% |
400,000
-100,000
| -20% | -$3.06M |
|
|
ARRY
832
DELISTED
Array Biopharma Inc
ARRY
| $12M | 0.02% |
2,632,022
+999,540
| +61% | +$5.93M |
|
833
Johnson Controls International
JCI
$86.6B
| $12M | 0.02% |
276,298
-2,354,205
| -89% | -$109M |
|
834
Mativ Holdings
MATV
$676M
| $11.9M | 0.02% |
346,331
+285,397
| +468% | +$10.4M |
|
835
InterDigital
IDCC
$8.8B
| $11.9M | 0.02% |
235,147
+111,416
| +90% | +$5.75M |
|
836
TherapeuticsMD
TXMD
$24M
| $11.9M | 0.02% |
40,453
-12,155
| -23% | -$4.32M |
|
|
CKEC
837
DELISTED
Carmike Cinemas Inc
CKEC
| $11.8M | 0.02% |
588,230
-303,046
| -34% | -$7.29M |
|
|
HME
838
DELISTED
HOME PROPERTIES, INC
HME
| $11.8M | 0.02% |
157,307
-785,159
| -83% | -$58.1M |
|
839
PBF Energy
PBF
$8.24B
| $11.8M | 0.02% |
416,522
-551,229
| -57% | -$16.7M |
|
|
TVRD
840
Tvardi Therapeutics
TVRD
$23.7M
| $11.8M | 0.02% |
22,844
+2,821
| +14% | +$1.89M |
|
841
Teradyne
TER
$57B
| $11.7M | 0.02% |
652,226
-108,805
| -14% | -$2.01M |
|
842
Usana Health Sciences
USNA
$251M
| $11.7M | 0.02% |
175,284
+161,474
| +1,169% | +$11.4M |
|
|
ITG
843
DELISTED
Investment Technology Group Inc
ITG
| $11.7M | 0.02% |
878,614
+390,985
| +80% | +$7.25M |
|
|
BXLT
844
DELISTED
BAXALTA INC COM STK (DE)
BXLT
| $11.7M | 0.02% |
+371,836
| New | +$12.8M |
|
845
Norwegian Cruise Line
NCLH
$7.91B
| $11.7M | 0.02% |
204,198
-456,615
| -69% | -$26.9M |
|
846
ProQR Therapeutics
PRQR
$343M
| $11.7M | 0.02% |
801,493
+52,960
| +7% | +$887K |
|
|
CIVI
847
DELISTED
Civitas Resources
CIVI
| $11.6M | 0.02% |
25,552
+2,685
| +12% | +$2.5M |
|
848
Clearway Energy Class C
CWEN
$6.63B
| $11.6M | 0.02% |
999,585
-1,181,288
| -54% | -$20.4M |
|
|
TPH
849
DELISTED
Tri Pointe Homes
TPH
| $11.6M | 0.02% |
885,000
+443,664
| +101% | +$6.42M |
|
|
LBMH
850
DELISTED
LIBERATOR MED HLDGS INC (NY)
LBMH
| $11.6M | 0.02% |
4,927,700
-2,600
| -0.1% | -$6.25K |
|
Similar funds
Israel Englander's Q3 2015 Portfolio in Review
As of Q3 2015, Israel Englander held 4,098 positions worth $51.6B, down 2.3% from $52.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Israel Englander deployed $5.12B of net new capital in Q3 2015, opening 839 new positions and adding to 1,320 existing holdings. Its largest new stake was BP: 4,551,492 shares worth $117M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 15% a quarter earlier, followed by Energy and Consumer Discretionary.
On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $229M trimmed.
- Israel Englander's largest Q3 2015 buy was BP: 4,551,492 shares worth $117M.
- Israel Englander added most to DuPont de Nemours in Q3 2015, an estimated $1.55B increase.
- Israel Englander's biggest Q3 2015 reduction was Alexion Pharmaceuticals, cutting an estimated $229M.
- Israel Englander fully exited PepsiCo in Q3 2015, selling an estimated $173M.
- Israel Englander's ten largest holdings make up 14% of its $51.6B portfolio in Q3 2015.
- Israel Englander opened 839 new positions and closed 681 in Q3 2015.
- Israel Englander's portfolio value fell 2.3% quarter-over-quarter to $51.6B.
Based on Millennium Management's 13F filing for Q3 2015, filed 16 Nov 2015.